EUVIMEDEUVIMED entdecken
Open Access

Development of an integrated sample amplification control for salivary point-of-care pathogen testing

Navaporn Sritong, Winston Wei Ngo, Karin F K Ejendal, Jacqueline C Linnes

Analytica Chimica Acta · 2024-01 · 1287 · 342072

DOI: 10.1016/j.aca.2023.342072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2024-01. Verfasst von Navaporn Sritong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN, USA. Hauptthemen laut MEDLINE: Point-of-Care Systems, Pandemics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NIAID NIH HHS, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The COVID-19 pandemic has led to a rise in point-of-care (POC) and home-based tests, but concerns over usability, accuracy, and effectiveness have arisen. The incorporation of internal amplification controls (IACs), essential control for translational POC diagnostics, could mitigate false-negative and false-positive results due to sample matrix interference or inhibition. Although emerging POC nucleic acid amplification tests (NAATs) for detecting SARS-CoV-2 show impressive analytical sensitivity in the lab, the assessment of clinical accuracy with IACs is often overlooked. In some cases, the IACs were run spatially, complicating assay workflow. Therefore, the multiplex assay for pathogen and IAC is needed. RESULTS: We developed a one-pot duplex reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) assay for saliva samples, a non-invasive and simple collected specimen for POC NAATs. The ORF1ab gene of SARS-CoV-2 was used as a target and a human 18S ribosomal RNA in human saliva was employed as an IAC to ensure clinical reliability of the RT-LAMP assay. The optimized assay could detect SARS-CoV-2 viral particles down to 100 copies/μL of saliva within 30 min without RNA extraction. The duplex RT-LAMP for SARS-CoV-2 and IAC is successfully amplified in the same reaction without cross-reactivity. The valid results were easily visualized in triple-line lateral flow immunoassay, in which two lines (flow control and IAC lines) represent valid negative results and three lines (flow control, IAC, and test line) represent valid positive results. This duplex assay demonstrated a clinical sensitivity of 95%, specificity of 100%, and accuracy of 96% in 30 clinical saliva samples. SIGNIFICANCE: IACs play a crucial role in ensuring user confidence with respect to the accuracy and reliability of at-home and POC molecular diagnostics. We demonstrated the multiplex capability of SARS-COV-2 and human18S ribosomal RNA RT-LAMP without complicating assay design. This generic platform can be extended in a similar manner to include human18S ribosomal RNA IACs into different clinical sample matrices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Point-of-Care SystemsPandemicsHumansReproducibility of ResultsPoint-of-Care TestingSARS-CoV-2RNA, Ribosomal

Stichwörter der Autor:innen

DiagnosticInternal amplification controlLateral flow immunoassayReverse transcription loop-mediated isothermal amplificationSARS-CoV-2Saliva

Substanzen

RNA, Ribosomal

Autor:innen und Institutionen

  • Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN, USA.
  • Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN, USA; Department of Public Health, Purdue University, West Lafayette, IN, USA. Electronic address: jlinnes@purdue.edu.

Förderung

  • NIDA NIH HHS
  • NIAID NIH HHS
  • National Institute on Drug Abuse
  • Gordon and Betty Moore Foundation
  • Purdue University

Zitieren

APA

Sritong, N., Ngo, W. W., Ejendal, K. F. K., & Linnes, J. C. (2024). Development of an integrated sample amplification control for salivary point-of-care pathogen testing. Analytica Chimica Acta, 1287, 342072. https://doi.org/10.1016/j.aca.2023.342072

Vancouver

Sritong N, Ngo WW, Ejendal KFK, Linnes JC. Development of an integrated sample amplification control for salivary point-of-care pathogen testing. Analytica Chimica Acta. 2024;1287:342072. doi:10.1016/j.aca.2023.342072

BibTeX
@article{Sritong2024,
  author = {Sritong, Navaporn and Ngo, Winston Wei and Ejendal, Karin F K and Linnes, Jacqueline C},
  title = {Development of an integrated sample amplification control for salivary point-of-care pathogen testing},
  journal = {Analytica Chimica Acta},
  year = {2024},
  volume = {1287},
  pages = {342072},
  doi = {10.1016/j.aca.2023.342072}
}
Kostenlos starten →